Anti-aging: telomere vs NAD+ pathway

Epithalon vs NAD+

Comparing Epithalon and NAD+ across evidence, dosing, mechanisms, and research areas.

vs
Category
longevity
longevity
Molecular weight
390.35 g/mol
663.43 g/mol
Half-life
~30 minutes (estimated, limited pharmacokinetic data)
~30-45 minutes (IV); ~2-4 hours (SubQ)
Admin routes
subcutaneousintravenous
intravenoussubcutaneousoral (NMN/NR precursors)transdermal
Research areas
Telomere extensionAnti-agingPineal gland functionMelatonin regulationWound healingDiabetic retinopathy
Anti-aging / longevityMitochondrial functionNeuroprotectionAddiction recoveryDNA repairMetabolic healthInflammation modulation
Typical dosing
5000–10000 mcg · 1x daily · 10-20 days, 2-3x per year
50000–500000 mcg · 1-2x weekly (SubQ) or monthly (IV) · Ongoing / maintenance protocol
FDA status
Not FDA-approved
Not FDA-approved as drug. NAD+ precursors (NMN, NR) available OTC as dietary supplements. IV/SubQ NAD+ available through clinics and compounding pharmacies
WADA status
Not listed
Not prohibited
PubMed studies
140
1,350

This comparison is for educational purposes only and does not constitute medical advice. Consult a qualified healthcare provider before using any peptide or supplement.

Source this stack
Epithalon11 vetted vendors

Save 15% with code VIALBASE

See all 11 sources →
NAD+10 vetted vendors

Save 15% with code VIALBASE

See all 10 sources →

VialBase may earn a commission on partner links — never at extra cost to you. Disclosure.